Justices Advised To Keep Law Clear In 'Skinny Label' Case
By Ryan Davis · March 10, 2026, 10:37 PM EDT
Several intellectual property groups have urged the U.S. Supreme Court to use a case involving "skinny labels" on generic drugs to set clear guidelines on what constitutes induced patent infringement, saying...
To view the full article, register now.